LEADER 01282nam 2200361 450 001 9910283657803321 005 20230814224125.0 010 $a1-5386-4752-4 035 $a(CKB)4100000005963636 035 $a(WaSeSS)IndRDA00121853 035 $a(EXLCZ)994100000005963636 100 $a20200413d2018 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$a2018 IEEE 10th Sensor Array and Multichannel Signal Processing Workshop $e8-11 July 2018, Sheffield, Sheffield, UK /$fInstitute of Electrical and Electronics Engineers 210 1$aPiscataway, New Jersey :$cInstitute of Electrical and Electronics Engineers,$d2018. 215 $a1 online resource (212 pages) 311 $a1-5386-4753-2 606 $aSignal processing$vCongresses 606 $aMultichannel communication$vCongresses 615 0$aSignal processing 615 0$aMultichannel communication 676 $a621.3822 712 02$aInstitute of Electrical and Electronics Engineers, 801 0$bWaSeSS 801 1$bWaSeSS 906 $aPROCEEDING 912 $a9910283657803321 996 $a2018 IEEE 10th Sensor Array and Multichannel Signal Processing Workshop$92544176 997 $aUNINA LEADER 04805nam 22006975 450 001 9910369953503321 005 20250610110342.0 010 $a3-030-02239-0 024 7 $a10.1007/978-3-030-02239-6 035 $a(CKB)4100000009273544 035 $a(DE-He213)978-3-030-02239-6 035 $a(MiAaPQ)EBC5896972 035 $a(PPN)258062657 035 $a(MiAaPQ)EBC29091033 035 $a(EXLCZ)994100000009273544 100 $a20190913d2020 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAnti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis /$fedited by Renato Alberto Sinico, Loïc Guillevin 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (X, 336 p. 52 illus., 35 illus. in color.) 225 1 $aRare Diseases of the Immune System,$x2282-6505 311 08$a3-030-02238-2 327 $aPreface -- 1 Introduction: Nomenclature and Classification -- 2 Epidemiology -- 3 Genetics -- 4 Pathogenesis B lymphocytes T lymphocytes -- 5 ANCA: methods and clinical significance -- 6 Activity and Damage -- 7 Eosinophilic Granulomatosis with Polyangiitis (EGPA) -- 8 Granulomatosis with Polyangiitis (GPA) -- 9 Microscopic Polyangiitis (MPA) -- 10 Vasculitis /organs involvement -- 11 ENT involvement -- 12 Lung involvement -- 13 Kidney involvement -- 14 Nervous system involvement. 15 Peripheral Nervous System -- 16 Central Nervous System -- 17 Skin involvement -- 18 Miscellaneous organ/system involvement (heart, gastrointestinal, articular?.) -- 19 Prognosis and outcome -- 20 Therapy -- Subject Index. 330 $aThis volume, written by well-known experts in the field, covers all aspects of Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV). The expression refers to a group of diseases, characterized by destruction and inflammation of small vessels. The clinical signs vary and affect several organs, such as the kidney, lung, skin, nervous system and others. The opening chapters give some historical hints, explain the genetic basis of the disease and provide insights into the pathogenesis derived from recent experimental studies and guides the reader through classification and nomenclature. A large part of the book is then devoted to a detailed description of the specific related diseases and their clinical presentations, the disease course, and potential complications. The advice regarding treatment is based on the best currently available evidence in this constantly evolving area. The book is part of Springer?s series Rare Diseases of the Immune System, which presents recently acquired knowledge on pathogenesis, diagnosis, and therapy with the aim of promoting a more holistic approach to these conditions. AAVs are systemic autoimmune diseases of unknown cause that affect small (to medium) sized blood vessels. They include granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (formerly Churg?Strauss syndrome). This volume will be an invaluable source of up-to-date information for all practitioners involved in the care of patients with these diseases. 410 0$aRare Diseases of the Immune System,$x2282-6505 606 $aRheumatology 606 $aNephrology 606 $aImmunology 606 $aInfectious diseases 606 $aOncology 606 $aRheumatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33170 606 $aNephrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33126 606 $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000 606 $aInfectious Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33096 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 615 0$aRheumatology. 615 0$aNephrology. 615 0$aImmunology. 615 0$aInfectious diseases. 615 0$aOncology. 615 14$aRheumatology. 615 24$aNephrology. 615 24$aImmunology. 615 24$aInfectious Diseases. 615 24$aOncology. 676 $a616.723 676 $a616.13 702 $aSinico$b Renato Alberto$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGuillevin$b Loïc$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910369953503321 996 $aAnti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis$92195568 997 $aUNINA